2020 World GI: Updates in HER2+ GI Cancers
Volume: 1
Issue: 1
Exploring Therapeutic Strategies in Myelodysplastic Syndromes
Volume: 2020
Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
OncLive® provides updates on the treatment of patients with diffuse large B-cell lymphoma through a Scientific Exchange Workshop.
ASCO 2020: Update on Genitourinary Cancers
Advanced HER2-Expressing Breast Cancer: An OncLive® Scientific Interchange and Workshop
My Treatment Approach: HER2-Positive Breast Cancer
Year in Review: Evolving Landscape in Multiple Myeloma
Therapeutic Changes in HER2+ Breast Cancer
Emerging Advances in Gastrointestinal Cancers
2020 Genitourinary Cancers Symposium
Therapeutic Updates in Neuroendocrine Tumors
2019 ESMO Immuno-Oncology Congress
BTK Inhibitors in B-Cell Lymphomas
Recent Advances in HER2+ Breast Cancer
Targeted Advances in ALK+ NSCLC
Rapid Reporter®
Pulmonologists in Cancer Care
Milestones in Medicine: History & Evolving Role of Interferon in Myeloproliferative Neoplasms
Dermatologists in Cancer Care®
Rapid Reviews in Oncology®
Dr Caimi on Early Data for LMY-920 in R/R B-Cell NHL
Navigating a “Sea Change” in Frontline Urothelial Carcinoma Treatment
Dr Scalici on Data for IMNN-001 Plus SOC Chemotherapy in Advanced Ovarian Cancer
Dr Lin on the Safety of NKTR-255 in Enhancing Immune Recovery Post-Chemoradiation in Locally Advanced NSCLC
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
%20(2)%201-Recovered-Recovered-Recovered-Recovered-Recovered.jpg?fit=crop&auto=format)
